STRAUSS ROBERT C 4
4 · NOVEN PHARMACEUTICALS INC · Filed Jan 12, 2006
Insider Transaction Report
Form 4
STRAUSS ROBERT C
DirectorPresident, CEO & Chairman
Transactions
- Exercise/Conversion
Common Stock ($ .0001 par value)
2006-01-10$5.63/sh+40,000$225,000→ 171,349 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-01-10−40,000→ 0 totalExercise: $5.63Exp: 2006-01-11→ Common Stock ($ .0001 par value) (40,000 underlying)
Footnotes (1)
- [F1]10% exercisable after 1/12/2000; 20% exercisable after 1/12/2001; 20% exercisable after 1/12/2002; 25% exercisable after 1/12/2003; 25% exercisable after 1/12/2004.